US$ 29.47
glp-1 receptor agonists in pediatric and adolescent obesity GLP1 Agonists—Effects beyond Diabetes GLP-1 receptor agonists in pediatric
Description
Funding There is no funding associated with this project

These statements reflect the brand's description and are not clinical findings for the finished product

doi: 10.1111/j.1463-1326.2011.01364.x 109 DunganKMPovedanoSTForstTGonzlezJGGAtissoCSeallsWet al

Some copay cards and patient assistance programs work even if the patients primary insurance doesnt cover the drug
